More than 11 million Americans have age-related macular degeneration (AMD), a leading cause of blindness in adults 60 years and older. As the population ages, this number will likely double by 2050, but there are no effective treatments. Dr. Francesca Marassi’s laboratory has discovered how a common blood protein orchestrates the deposition of lipid, cholesterol and calcifications that are a hallmark of AMD. Join Dr. Marassi as she shares how this information will guide the development of future AMD therapies.